Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia

Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia

Multivariable analysis for overall survival and relapse‐free survival demonstrating lack of significant for D14 BM status.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hematology 2024-10, Vol.99 (10), p.2026-2028
Hauptverfasser: Balev, Metodi, Zibara, Victor, Van Hyfte, Grace, Feld, Jonathan, Kremyanskaya, Marina, Becker, Michelle, Keyzner, Alla, Shih, Alan H., Marcellino, Bridget, Levavi, Hannah, Silverman, Lewis, Mascarenhas, John, Tremblay, Douglas
Format: Artikel
Sprache:eng
Schlagworte:
Acute myeloid leukemia
Biopsy
Survival
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Multivariable analysis for overall survival and relapse‐free survival demonstrating lack of significant for D14 BM status.
ISSN:0361-8609
1096-8652
1096-8652
DOI:10.1002/ajh.27429